The Effect of 8 Weeks Interval Exercises and Vitamin D Supplementation on Plasma Levels of Dipeptidyl peptidase-4 and retinol binding protein 4 in Overweight Women

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170510033909N3

Enrollment

Registered

2019-05-21

Start date

2019-02-28

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

over weaight woman.

Interventions

Intervention 1: First intervention group: Interval exercise, which includes three sessions per week each session for an eight-week session. Intervention 2: 'Intervention Group 2: Vitamin D was consume

Eligibility

Sex/Gender

Female

Age

35 Years to 45 Years

Inclusion criteria

Inclusion criteria: The criteria for entering the study include the absence of any ischemic heart disease, kidney, , non-use of lipid lowering drugs the inability of people to participate in a specific weight loss program the inability of people to participate in a specific physical program woman with over weight 35-45 year old

Exclusion criteria

Exclusion criteria: Interrupting or not participating in exercises Do not take vitamin D supplements Participant withdrawal

Design outcomes

Primary

Measure	Time frame
Dpp4. Timepoint: At the beginning and end of the study. Method of measurement: DPP4 using the biometric group of Australian group kit by ELISA method.;Rbp4. Timepoint: At the beginning and end of the study. Method of measurement: Rbp4 using the biometric group of Australian group kit by ELISA method.	—

Secondary

Measure	Time frame
Serum insulin concentration. Timepoint: Before the intervention and after eight weeks of study. Method of measurement: , Serum insulin concentration by ELISA method and use of special kit, Monobind Inc., USA) (75 µg / ml micro-unit per ml, intra-group variation coefficient of 6.3%),.;Serum glucose concentration. Timepoint: Before the intervention and after eight weeks of study. Method of measurement: , Serum glucose concentration was measured by enzymatic calorimetric method (sensitivity of 5 ml / dl and internal variation coefficient of 2.5%).;Insulin resistance. Timepoint: Before the intervention and after eight weeks of study. Method of measurement: Insulin resistance was used to evaluate the HOMA-IR homeostasis model by measuring insulin and fasting glucose according to the following formula.Serum glucose level in fasting state (MI / L). Serum insulin level in fasting state (MIU / L). Insulin resistance.5/22.	—

Measure

Time frame

Serum insulin concentration. Timepoint: Before the intervention and after eight weeks of study. Method of measurement: , Serum insulin concentration by ELISA method and use of special kit, Monobind Inc., USA) (75 µg / ml micro-unit per ml, intra-group variation coefficient of 6.3%),.;Serum glucose concentration. Timepoint: Before the intervention and after eight weeks of study. Method of measurement: , Serum glucose concentration was measured by enzymatic calorimetric method (sensitivity of 5 ml / dl and internal variation coefficient of 2.5%).;Insulin resistance. Timepoint: Before the intervention and after eight weeks of study. Method of measurement: Insulin resistance was used to evaluate the HOMA-IR homeostasis model by measuring insulin and fasting glucose according to the following formula.Serum glucose level in fasting state (MI / L). Serum insulin level in fasting state (MIU / L). Insulin resistance.5/22.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHajar Bahador

Islamic Azad University

A.h.bahador2017@gmail.com+98 31 3345 7663

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026